Market Research Logo

World Bleeding Disorders Treatment Market 2017-2027

World Bleeding Disorders Treatment Market 2017-2027

Bleeding Disorder Treatment – our new study reveals trends, R&D progress, and predicted revenues

Where is the Bleeding Disorder Treatment market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead

Our 172-page report provides 153 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Bleeding Disorder Treatment market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets

Along with revenue prediction for the overall world market, there are forecasts for 7 Bleeding Disorder Treatment Types, each forecasted at a global and regional level.

Bleeding Disorder Treatments, by Indication
  • Haemophilia A
  • Haemophilia B
  • Von Willebrand Disease (VWD)
  • Other Bleeding Disorders
Bleeding Disorder Treatments, by Drug Class
  • Plasma-derived Coagulation Factor Concentrates
  • Factor VIII
  • Factor IX
  • Von Willebrand Disease Factor
  • Prothrombin Complex Concentrate Factor
  • Recombinant Coagulation Factor Concentrates:
  • Factor VIII
  • Factor IX
  • Von Willebrand Disease Factor
  • Desmopressin
  • Antifibrinolytics
  • Fibrin Sealants
  • Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 19 leading national markets:
  • North America:
  • The U.S.
  • Canada
  • Mexico
  • South America:
  • Brazil
  • Argentina
  • Paraguay
  • Bolivia
  • Rest of South America
  • Europe:
  • Germany
  • France
  • The UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific:
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • Rest of Asia
  • Rest of World (RoW):
  • Middle East
  • Africa
  • Other Countries
The report also includes profiles and for some of the leading companies in the Bleeding Disorder Treatment market, with a focus on this segment of these companies’ operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and Australia in particular, will continue to achieve high revenue growth to 2027.

Leading companies and the potential for market growth

Overall world revenue for Bleeding Disorder Treatment will surpass $6bn in 2017, our work calculates. We predict strong revenue growth through to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Bleeding Disorder Treatment Market report helps you

In summary, our 172-page report provides you with the following knowledge:
  • Revenue forecasts to 2027 for the Bleeding Disorder Treatment market with forecasts for 4 Indications and 5 Drug Classes – discover the industry’s prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2027 for 5 regional and 19 key national markets – see forecasts for the Bleeding Disorder treatment market in North America, South America, Europe, Asia-Pacific and the rest of the world. Also analysed are the national markets in the US, Canada, Mexico, Brazil, Argentina, Paraguay, Bolivia, Germany, France, the UK, Italy, Spain, Japan, China, India, Australia, Thailand, the Middle East and Africa.
  • Discussion of what stimulates and restrains companies and the market
  • Prospects for established firms and those seeking to enter the market – including company profiles for 10 of the major companies involved in the Bleeding Disorder Treatment market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly updated report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain’s study is for everybody needing commercial analyses for the Bleeding Disorder Treatment market and leading companies. You will find data, trends and predictions.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

The publisher is using a password system to access all reports. Single user (non-printable) and departmental licenses expires after 12 month period. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.


1. Report Overview
1.1 Global Bleeding Disorders Treatment Market Overview
1.2 Market Definition
1.3 Research Methodology
1.3.1 Primary Research
1.3.2 Secondary Research
1.3.3 Market Evaluation & Forecasting Methodology
1.4 Global Bleeding Disorders Treatment Market Segmentation
1.5 Structure of the Report
1.6 Why You Should Read This Report
1.7 How this Report Delivers
1.8 Key Questions Answered by This Analytical Report
1.9 Frequently Asked Questions (FAQ)
1.10 Who is This Report For?
1.11 Associated Visiongain Reports
1.12 About Visiongain
2. Introduction to Bleeding Disorders Treatment Market
3. Global Bleeding Disorders Treatment Market Forecast to 2027
4. Global Bleeding Disorders Treatment Market by Indication Forecast to 2027
4.1 Overview
4.2 Haemophilia A
4.3 Haemophilia B
4.4 Von Willebrand Disease (VWD)
4.5 Others
5. Global Bleeding Disorders Treatment Market by Drug Class: Market Forecast to 2027
5.1 Overview
5.2 Plasma-derived Coagulation Factor Concentrates
5.2.1 Factor VIII
5.2.2 Factor IX
5.2.3 Von Willebrand Disease Factor
5.2.4 Factor Prothrombin Complex Concentrate
5.3 Recombinant Coagulation Factor Concentrates
5.3.1 Factor VIII
5.3.2 Factor IX
5.3.3 Von Willebrand Disease Factor
5.4 Desmopressin
5.5 Antifibrinolytics
5.6 Fibrin Sealants
5.7 Others
6. Regional Bleeding Disorders Treatment Market Forecasts to 2027
6.1 Regional Bleeding Disorders Treatment Market Forecast Overview
6.2 North American Bleeding Disorders Treatment Market Forecast 2016-2027
6.2.1 USA Bleeding Disorders Treatment Market Forecast 2016-2027
6.2.2 Canada Bleeding Disorders Treatment Market Forecast 2016-2027
6.2.3 Mexico Bleeding Disorders Treatment Market Forecast 2016-2027
6.3 South American Bleeding Disorders Treatment Market Forecast 2016-2027
6.3.1 Brazil Bleeding Disorders Treatment Market Forecast 2016-2027
6.3.2 Argentina Bleeding Disorders Treatment Market Forecast 2016-2027
6.3.3 Paraguay Bleeding Disorders Treatment Market Forecast 2016-2027
6.3.4 Bolivia Bleeding Disorders Treatment Market Forecast 2016-2027
6.3.5 Rest of South America Bleeding Disorders Treatment Market Forecast 2016-2027
6.4 European Bleeding Disorders Treatment Market Forecast 2016-2027
6.4.1 France Bleeding Disorders Treatment Market Forecast 2016-2027
6.4.2 Germany Bleeding Disorders Treatment Market Forecast 2016-2027
6.4.3 UK Bleeding Disorders Treatment Market Forecast 2016-2027
6.4.4 Spain Bleeding Disorders Treatment Market Forecast 2016-2027
6.4.5 Italy Bleeding Disorders Treatment Market Forecast 2016-2027
6.4.6 Rest of Europe Bleeding Disorders Treatment Market Forecast 2016-2027
6.5 Asia-Pacific Bleeding Disorders Treatment Market Forecast 2016-2027
6.5.1 China Bleeding Disorders Treatment Market Forecast 2016-2027
6.5.2 Japan Bleeding Disorders Treatment Market Forecast 2016-2027
6.5.3 India Bleeding Disorders Treatment Market Forecast 2016-2027
6.5.4 Australia Bleeding Disorders Treatment Market Forecast 2016-2027
6.5.5 Thailand Bleeding Disorders Treatment Market Forecast 2016-2027
6.5.6 Rest of Asia-Pacific Bleeding Disorders Treatment Market Forecast 2016-2027
6.6 Rest of World Bleeding Disorders Treatment Market Forecast 2016-2027
6.6.1 Middle East Bleeding Disorders Treatment Market Forecast 2016-2027
6.6.2 Africa Cancer Bleeding Disorders Treatment Forecast 2016-2027
6.6.3 Other Countries Bleeding Disorders Treatment Market Forecast 2016-2027
7. Bleeding Disorders Treatment Market, Qualitative Analysis, 2016-2027
7.1 Porter’s Five Forces Analysis of the Bleeding Disorders Treatment Market 2016-2027
7.1.1 Bargaining Power of Buyers (Low)
7.1.2 Bargaining Power of Suppliers (Medium)
7.1.3 Threat of New Entrants (Low)
7.1.4 Threat of Substitute Products (Low)
7.1.5 Intensity of Competitive Rivalry (High)
7.2 Drivers, Restrains & Opportunities
7.2.1 Drivers
7.2.2 Restraints
7.2.3 Opportunities
8. Leading Companies in Bleeding Disorders Treatment Market
8.1 Novo Nordisk A/S (Novo Nordisk)
8.1.1 Novo Nordisk: Company Overview
8.1.2 Novo Nordisk: Financial Overview
8.1.3 Novo Nordisk: Product Portfolio
8.1.4 Novo Nordisk: Recent Developments
8.2 Bristol-Myers Squibb
8.2.1 Bristol-Myers Squibb: Company Overview
8.2.2 Bristol Myers Squibb: Financial Overview
8.2.3 Bristol-Myers Squibb: Product Portfolio
8.2.4 Bristol-Myers Squibb: Recent Developments
8.3 Pfizer Inc.
8.3.1 Pfizer Inc.: Company Overview
8.3.2 Pfizer, Inc.: Financial Overview
8.3.3 Pfizer Inc.: Product Portfolio
8.3.4 Pfizer Inc.: Recent Developments
8.4 Bayer AG
8.4.1 Bayer AG: Company Overview
8.4.2 Bayer AG: Financial Overview
8.4.3 Bayer AG: Product Portfolio
8.4.4 Bayer AG: Recent Developments
8.5 CSL, LTD. (CSL)
8.5.1 CSL: Company Overview
8.5.2 CSL Financial Overview
8.5.3 CSL.: Product Portfolio
8.5.4 CSL: Recent Developments
8.6 Grifols S.A. (Grifols)
8.6.1 Grifols: Company Overview
8.6.2 Grifols: Financial Overview
8.6.3 Grifols: Product Portfolio
8.6.4 Grifols: Recent Developments
8.7 Octapharma AG (Octapharma)
8.7.1 Octapharma: Company Overview
8.7.2 Octapharma: Financial Overview
8.7.3 Octapharma: Product Portfolio
8.7.4 Octapharma: Recent Developments
8.8 Shire PLC (Shire)
8.8.1 Shire: Company Overview
8.8.2 Shire: Financial Overview
8.8.3 Shire: Product Portfolio
8.8.4 Shire: Recent Developments
8.9 Sanofi
8.9.1 Sanofi: Company Overview
8.9.2 Sanofi: Financial Overview
8.9.3 Sanofi: Product Portfolio
8.9.4 Sanofi: Recent Developments
8.10 Kedrion S.P.A (Kedrion)
8.10.1 Kendrion: Company Overview
8.10.2 Kedrion: Financial Overview
8.10.3 Kedrion: Product Portfolio
8.10.4 Kedrion: Recent Developments
8.11 Other Companies in the Bleeding Disorders Treatment Market
9. Conclusions
9.1 Current Leading Segments
9.2 Leading Regional Markets
9.3 Emerging Markets
9.4 The Future of the Market?
10. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
List of Figures
Figure 1.1. Bleeding Disorders Treatment Market Segmentation
Figure 2.1 Top winning Strategies of Market Players in Bleeding Disorders Market, 2014-2016
Figure 3.1 Bleeding Disorders Treatment, by Type, ($m), 2016-2027
Figure 3.2 Global Bleeding Disorders Treatment Market, by Drug Class, ($m), 2016-2027
Figure 4.1. Global Bleeding Disorders Treatment Market Forecast, by Type ($m) 2016-2027
Figure 4.2 Bleeding Disorders Treatment Market, by Type, Market Share (%), 2016
Figure 4.3 Global Haemophilia A for Bleeding Disorders Treatment Market Forecast, by Geography, ($m) 2016-2027
Figure 4.4 Global Haemophilia B for Bleeding Disorders Treatment Market Forecast, by Geography, ($m) 2016-2027
Figure 4.5 Global Von Willebrand Disease for Bleeding Disorders Treatment Market Forecast, by Geography, ($m) 2016-2027
Figure 4.6 Global Other Bleeding Disorders Treatment Market Forecast, by Geography, ($m) 2016-2027
Figure 5.1. Global Bleeding Disorder Treatment Market: Drug Class Segmentation
Figure 5.2. Global Bleeding Disorders Treatment Market, by Application, Market Share (%), 2016
Figure 5.3. Global Bleeding Disorders Treatment Market for Plasma-derived Coagulation Factor Concentrates Forecast, by Geography($m) 2016-2027
Figure 5.4. Global Bleeding Disorders Treatment Market for Recombinant Coagulation Factor Concentrates Forecast, by Geography($m) 2016-2027
Figure 5.5. Global Bleeding Disorders Treatment Market for Desmopressin Forecast, by Geography($m) 2016-2027
Figure 5.6. Global Bleeding Disorders Treatment Market for Antifibrinolytics Forecast, by Geography($m) 2016-2027
Figure 5.7. Global Bleeding Disorders Treatment Market for Fibrin Sealants Forecast, by Geography($m) 2016-2027
Figure 5.8. Global Bleeding Disorders Treatment Market for Other Drug Classes Forecast, by Geography($m) 2016-2027
Figure 6.1. Global Bleeding Disorders Treatment Market Forecast, by Geography, by Geography($m) 2016-2027
Figure 6.2. Global Bleeding Disorders Treatment Market Forecast, by Geography, Market Share (%), 2016
Figure 6.3. North America Bleeding Disorders Treatment Market Forecast, by Country($m) 2016-2027
Figure 6.4. North America Bleeding Disorders Treatment Market, by Country, Market Share (%), 2016
Figure 6.5. USA Bleeding Disorders Treatment Market Forecast ($m) 2016-2027
Figure 6.6 Percentage of people with Haemophilia A (Statistic, 2014)
Figure 6.7. Canada Bleeding Disorders Treatment Market Forecast ($m) 2016-2027
Figure 6.8 Mexico Bleeding Disorders Treatment Market Forecast ($m) 2016-2027
Figure 6.9 South America Bleeding Disorders Treatment Market Forecast, by Country($m) 2016-2027
Figure 6.10. South America Bleeding Disorders Treatment Market, by Country, Market Share (%), 2016
Figure 6.11. Brazil Bleeding Disorders Treatment Market Forecast ($m) 2016-2027
Figure 6.12. Argentina Bleeding Disorders Treatment Market Forecast ($m) 2016-2027
Figure 6.13. Paraguay Bleeding Disorders Treatment Market Forecast ($m) 2016-2027
Figure 6.14. Bolivia Bleeding Disorders Treatment Market Forecast ($m) 2016-2027
Figure 6.15. Rest of South America Bleeding Disorders Treatment Market Forecast ($m) 2016-2027
Figure 6.16. Europe Bleeding Disorders Treatment Market Forecast, by Country($m) 2016-2027
Figure 6.17. Europe Bleeding Disorders Treatment Market, by Country, Market Share (%), 2016
Figure 6.18. France Bleeding Disorders Treatment Market Forecast ($m) 2016-2027
Figure 6.19. Germany Bleeding Disorders Treatment Market Forecast ($m) 2016-2027
Figure 6.20. UK Bleeding Disorders Treatment Market Forecast ($m) 2016-2027
Figure 6.21. Spain Bleeding Disorders Treatment Market Forecast ($m) 2016-2027
Figure 6.22. Italy Bleeding Disorders Treatment Market Forecast ($m) 2016-2027
Figure 6.23. Rest of Europe Bleeding Disorders Treatment Market Forecast ($m) 2016-2027
Figure 6.24. Asia-Pacific Bleeding Disorders Treatment Market Forecast, by Country($m) 2016-2027
Figure 6.25. Asia-Pacific Bleeding Disorders Treatment Market, Market Share (%), 2016
Figure 6.26. China Bleeding Disorders Treatment Market Forecast ($m) 2016-2027
Figure 6.27. Japan Bleeding Disorders Treatment Market Forecast ($m) 2016-2027
Figure 6.28. India Bleeding Disorders Treatment Market Forecast ($m) 2016-2027
Figure 6.29. Australia Bleeding Disorders Treatment Market Forecast ($m) 2016-2027
Figure 6.30. Thailand Bleeding Disorders Treatment Market Forecast ($m) 2016-2027
Figure 6.31. Rest of Asia-Pacific Bleeding Disorders Treatment Market Forecast ($m) 2016-2027
Figure 6.32. RoW Bleeding Disorders Treatment Market Forecast, by Country($m) 2016-2027
Figure 6.33. Rest of World Bleeding Disorders Treatment Market, by Country, Market Share (%), 2016
Figure 6.34. Middle East Bleeding Disorders Treatment Market Forecast ($m) 2016-2027
Figure 6.35. Africa Bleeding Disorders Treatment Market Forecast ($m) 2016-2027
Figure 6.36. Other Countries Bleeding Disorders Treatment Market Forecast ($m) 2016-2027
Figure 7.1 Porter’s Five Forces Analysis of the Bleeding Disorders Treatment Market
Figure 9.1 World Bleeding Disorders Treatment, by Type, ($m), 2016-2027
Figure 9.2 World Bleeding Disorders Treatment, by Drug Type, ($m), 2016-2027
Figure 9.3. World Bleeding Disorders Treatment, by Geography, ($m), 2016-2027
List of Tables
Table 2.1 Global Demographics: People suffering from haemophilia and other bleeding disorders
Table 3.1. Global Bleeding Disorders Treatment Market Forecast ($m, AGR%, CAGR%) 2016-2027
Table 4.1 Bleeding Disorders Treatment Market, by Type, Forecast ($m, AGR%, CAGR%) 2016-2027
Table 4.2.Key Haemophilia A Drugs approved by FDA
Table 4.3. Global Haemophilia A for Bleeding Disorders Treatment Market Forecast, ($m, AGR%, CAGR%) 2016-2027
Table 4.4. Global Haemophilia A for Bleeding Disorders Treatment Market Forecast, by Geography, ($m, AGR%, CAGR%) 2016-2027
Table 4.5.Key Haemophilia B Drugs approved by FDA
Table 4.6. Global Haemophilia B for Bleeding Disorders Treatment Market Forecast, ($m, AGR%, CAGR%) 2016-2027
Table 4.7. Global Haemophilia B for Bleeding Disorders Treatment Market Forecast, by Geography ($m, AGR%, CAGR%) 2016-2027
Table 4.8. Global Von Willebrand Disease for Bleeding Disorders Treatment Market Forecast, ($m, AGR%, CAGR%) 2016-2027
Table 4.9. Global Von Willebrand Disease for Bleeding Disorders Treatment Market, by Geography ($m, AGR%, CAGR%) 2016-2027
Table 4.10. Global Other Bleeding Disorders Treatment Market Forecast, ($m, AGR%, CAGR%) 2016-2027
Table 4.11. Global Other Bleeding Disorders Treatment Market Forecast, by Geography ($m, AGR%, CAGR%) 2016-2027
Table 5.1. Global Blood Disorders Treatment Market, by Drug Class($m, AGR%, CAGR%) 2016-2027
Table 5.2. Types of Monoclonal Antibodies
Table 5.3. Global Bleeding Disorders Treatment Market for Plasma-Derived Coagulation Factor Concentrates, ($m, AGR%, CAGR%) 2016-2027

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report